The results demonstrated that GBM patients with high expression of Notch3 at protein levels presented with a poor prognosis, while the expression of Notch1, Notch2, and Notch4 showed no relation to GBM patient survival, which was consistent with the results in TCGA and CGGA at mRNA levels (Figures 4C–F). This evidence concerns the gene NOTCH1 and glioblastoma.